NCT04350476

COVID-19 Remote Monitoring

Remote Monitoring in Patients With Coronavirus Disease (COVID-19)

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Vivek Reddy · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.

Detailed description

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.

Conditions

• COVID-19
• Cardiac Arrhythmias

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	VitalConnect Vital Sign Patch	This patch provides continuous real-time monitoring of cardiac telemetry, heart rate, respiratory rate and oxygen saturation. Duration of monitoring is typically up to 7 days. This patch is applied to the upper left side of the chest wall, attached with a hypoallergenic adhesive material. (This device is FDA approved for this indication).

Timeline

• Start date: 2020-04-17
• Primary completion: 2020-05-01
• Completion: 2020-05-01
• First posted: 2020-04-17
• Last updated: 2020-08-20

Regulatory

• FDA-regulated device study